Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Rr Mcl News

Rr Mcl News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rr Mcl. Real-time updates on events, politics, business and more.

Ibrutinib Combined With Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis Results From the Randomized Phase 3 SYMPATICO Study

February 20, 2024
Michael Wang, MD, presents the primary analysis results from the multinational, randomized, double-blind, phase 3 SYMPATICO study comparing ibrutinib plus venetoclax vs ibrutinib plus placebo in patients with relapsed/refractory mantle cell lymphoma (R/R MCL).
Ibrutinib Combined With Venetoclax Patients With Refractory Mantle Cell Lymphoma Primary Analysis Results From Randomized Phase Mantle Cell Lymphoma
Source: onclive.com

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

December 6, 2023
Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma.
Alexey Danilov Lisocabtagene Maraleucel International Conference On Malignant Lymphoma Primary Analysis Results Seamless Design Partnership With
Source: onclive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science